How to define the relative contraindications to oral anticoagulant therapy

Area of Science:

• Cardiology
• Pharmacology
• Clinical Medicine

Background:

• Current guidelines lack clear definitions for absolute versus relative contraindications to anticoagulant therapy.
• European Society of Cardiology guidelines for atrial fibrillation (AF) incorporate risk factors into scores but still allow for clinical judgment.

Purpose of the Study:

• To clarify the distinction between absolute and relative contraindications for anticoagulant therapy.
• To propose an optimized approach for managing bleeding risk in patients undergoing anticoagulant therapy.

Main Methods:

• Review of current anticoagulant therapy guidelines, focusing on contraindications and bleeding risk assessment.
• Analysis of the role of risk scores versus clinical judgment in decision-making.

Main Results:

• A high bleeding risk score alone should not contraindicate anticoagulant therapy.
• Identifiable and treatable bleeding risk factors should be addressed proactively.

Conclusions:

• A hierarchical classification of bleeding risk factors combined with risk scores offers the best strategy.
• This approach aims to maximize the benefits of anticoagulant therapy across diverse clinical scenarios.